ELV Insider Trading Activity and SEC Form 4 Filings
Trump's trades in ELV
From his financial disclosures
$66K+
3 purchases
$265K+
2 sales
Purchase
Apr 27, 2026
Reported 65d later
$15K - $50K
Purchase
Apr 27, 2026
Reported 65d later
$1K - $15K
Purchase
Apr 10, 2026
Reported 82d later
$50K - $100K
Sale
Mar 18, 2026
Reported 57d later
$15K - $50K
Sale
Mar 17, 2026
Reported 58d later
$250K - $500K
Many orders in these accounts are placed by the account manager.
ELV insider trading summary
Over the past 12 months, insiders at Elevance Health, Inc. (ELV) reported 19 sales worth $7.0M by 6 insiders and 4 open-market purchases worth $2.2M by 3 insiders on SEC Form 4. Net insider selling was $4.7M.
Latest ELV insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 5, 2026 | Ratnakar Lavu | EVP & Chief Digital Info Ofr | Sell | $572K (1,300 @ $440.00) |
| Oct 22, 2026 | Mark Kaye | EVP & CFO | Sell | $1.0M (2,343 @ $441.34) |
| Oct 22, 2026 | Mark Kaye | EVP & CFO | Sell | $105K (240 @ $438.22) |
| Oct 22, 2026 | Mark Kaye | EVP & CFO | Sell | $510K (1,160 @ $439.25) |
| Oct 22, 2026 | Mark Kaye | EVP & CFO | Sell | $140K (321 @ $435.25) |
| Oct 22, 2026 | Mark Kaye | EVP & CFO | Sell | $724K (1,660 @ $436.20) |
| Oct 22, 2026 | Mark Kaye | EVP & CFO | Sell | $758K (1,720 @ $440.44) |
| Oct 22, 2026 | Mark Kaye | EVP & CFO | Sell | $174K (400 @ $434.00) |
| Oct 22, 2026 | Mark Kaye | EVP & CFO | Sell | $245K (560 @ $437.07) |
| Oct 22, 2026 | Mark Kaye | EVP & CFO | Sell | $212K (480 @ $442.61) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.